Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Tumeo will lead the ChemComp project, which was awarded for Exploratory Research in Extreme Scale Science

PNNL is collaborating with Microsoft, Micron and other partners to make computational chemistry broadly available.

PNNL data scientist in the Biological Sciences Division won the 2023 JSM Data Challenge Expo. The award-winning analysis focused on the ability to identify crime patterns by correlating them with historical events and trends.

PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.

Bobbie-Jo Webb-Robertson is a leader with a PhD in decision sciences & engineering systems from Rensselaer Polytechnic Institute and experience in managing complex scientific programs and line organizations. She assumed the role 3/13/23.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

We are pleased to welcome 20 new joint appointees to PNNL.

Parallel graph neural networks identify protein-ligand 3-D structural interactions to aid in protein function prediction and drug discovery.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.